ArticleIn vivo (Athens, Greece)
Dynamics of the Interleukin-10 Family of Cytokines in Chronic Otitis Media Patients upon 1,8-Cineol Treatment.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimThe monoterpene 1,8-Cineol is a natural plant-based anti-inflammatory agent that is used to treat different respiratory diseases with regard to its mucolytic and anti-microbial properties. 1,8-Cineol has recently been shown to support the natural microbial colonization of the middle ear, the intestinal bacterial community, as well as the clinical inflammatory situation of patients with chronic otitis media (COM). The aim of this study was to understand better the influence of 1,8-Cineol treatment on the systemic balances of inflammatory mediators of the interleukin-10 (IL-10) family of cytokines. PATIENTS AND
methodsPlasma concentrations of cytokines IL-10, IL-19, IL-20, Il-22, IL-24 and IL-26 were analyzed in patients with COM with regard to 1,8-Cineol (CNL-1976
resultsData revealed significantly increased concentrations of cytokines IL-19 and IL-26 in plasma samples from patients with COM compared to healthy donors as well as a significant positive correlation between IL-10 and IL-19. Of note, patients with COM revealed significantly reduced plasma levels of IL-26 in response to 14 days of 1,8-Cineol administration.
conclusion1,8-Cineol treatment actively modulates the systemic inflammatory environment in patients with chronic otitis media. By resetting disrupted cytokine balances, this plant-based agent offers a promising, target-specific therapeutic strategy for managing persistent middle ear inflammation and potentially mitigating associated systemic comorbidities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.